The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
Clicks: 281
ID: 273383
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.2
/100
281 views
61 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #5 of 9 articles by views in molecular cancer
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Aberrations in the Wnt pathway have been reported to be involved in the metastasis of prostate cancer (PCa) to bone. We investigated the effect and underlying mechanism of a naturally-occurring Wnt inhibitor, WIF1, on the growth and cellular invasiveness ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (39 words).
Try re-searching for a better abstract.
| Reference Key |
zi2010molecularthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | David S Yee, Yaxiong Tang, Xuesen Li, Zhongbo Liu, Yi Guo, Samia Ghaffar, Peter McQueen, Dash Atreya, Jun Xie, Anne R Simoneau, Bang H Hoang, Xiaolin Zi;David S Yee;Yaxiong Tang;Xuesen Li;Zhongbo Liu;Yi Guo;Samia Ghaffar;Peter McQueen;Dash Atreya;Jun Xie;Anne R Simoneau;Bang H Hoang;Xiaolin Zi; |
| Journal | molecular cancer |
| Year | 2010 |
| DOI |
10.1186/1476-4598-9-162
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.